Skip to main content

Table 2 Plasma hTERT mRNA level in NPC patients and its association with clinicopathological factors

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Factor No. hTERT mRNA (2-Ct)
(X ± SD)
F/t value P value
Gender
 Male 16 10.48 ± 4.39 −0.346 0.731
 Female 17 11.00 ± 4.31
Age
  < 50 yrs 17 11.04 ± 4.84 0.395 0.696
  ≥ 50 yrs 16 10.44 ± 3.75
Clinical stage
 I 4 3.35 ± 1.07 32.457 <0.001
 II 5 7.46 ± 0.91
 III 17 11.17 ± 2.06
 IV 7 15.18 ± 2.93
N Stage
 N0 4 3.35 ± 1.07 18.625 <0.001
 N1 5 7.40 ± 0.95
 N2 17 12.04 ± 3.15
 N3 7 14.23 ± 2.44
T Stage
 T1 11 6.93 ± 3.34 20.839 <0.001
 T2 6 9.67 ± 2.66
 T3 13 12.65 ± 1.72
 T4 3 18.67 ± 1.53